Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Arg-Gly-Asp engineered mesenchymal stem cells as targeted nanotherapeutics against kidney fibrosis by modulating m6A

31 Mar 2025

Abstract excerpt

Background The recent surge in research on extracellular vesicles has generated considerable interest in their clinical applications. Extracellular vesicles derived from mesenchymal stem cells (MSC-EV) have emerged as a promising cell-free therapy for chronic kidney disease (CKD), offering an alternative to traditional Mesenchymal stem/stromal cells (MSCs) in extracellular vesicle-based nanotherapeutics. However,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Peptidase Inhibition and Analysis
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40158765
DOI: 10.1016/j.actbio.2025.03.042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Arg-Gly-Asp engineered mesenchymal stem cells as targeted nanotherapeutics against kidney fibrosis by modulating m6APMID 40158765Read ↗

<span class="word">A <span class="word">Comprehensive <span class="word">Review <span class="word">of <span class="word">Engineered <span class="word">Bone <span class="word">Marrow <span class="word">Mesenchymal <span class="word">Stem <span class="word">Cell-<span class="word">Derived <span class="word">Exosomes <span class="word">as <span class="word">Nanotheranostic <span class="word">Platforms <span class="word">for <span class="word">Acute <span class="word">and <span class="word">Chronic…Semantic proximity Read ↗

Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal RepairSemantic proximity Read ↗

Engineered extracellular vesicles promote the repair of acute kidney injury by modulating regulatory T cells and the immune microenvironmentSemantic proximity Read ↗

Enhanced Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Renal Ischemic InjurySemantic proximity Read ↗

Renal Tubular Cell-Derived Extracellular Vesicles Accelerate the Recovery of Established Renal Ischemia Reperfusion Injury.Semantic proximity Read ↗

Ultrafiltration Segregates Tissue Regenerative Stimuli Harboured Within and Independent of Extracellular VesiclesSemantic proximity Read ↗

Extracellular Vesicle-Enriched Secretome from Mesenchymal Stromal Cells Protects Against Chemically, Particulate-, and Ischemia-Induced Innate-Immunity Induced InflammationSemantic proximity Read ↗

Exosomes as nanostructures deliver miR-204 in alleviation of mitochondrial dysfunction in diabetic nephropathy through suppressing methyltransferase-like 7A-mediated CIDEC N6-methyladenosine methylationSemantic proximity Read ↗

GDNF-engineered AMSC-derived exosomes attenuate renal interstitial fibrosis by promoting peritubular capillary regeneration via miR-29c-3p–IFN-γ–SIRT1 signalingSemantic proximity Read ↗

HucMSC-EVs Attenuate Renal Fibrosis via miR-874-3p- Mediated Inhibition of cGAS–STING SignalingSemantic proximity Read ↗

Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failureSemantic proximity Read ↗

Extracellular vesicles produced by bone marrow mesenchymal stem cells attenuate renal fibrosis, in part by inhibiting the RhoA/ROCK pathway, in a UUO rat modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.